Contract Pharma

Breaking News | Industry News | Injectables

Keystone Expands Capacity for Vial & Syringe Packaging

Spurred by increased demand from biologics and vaccines sectors

Contract Pharma Staff 04.15.20

Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trials | Drug Development | Scale-up/Technology Transfer

Rapid Delivery of Medical Countermeasures Amid Pandemic

Robert Erwin of iBio discusses the company’s COVID-19 vaccine development efforts and FastPharming manufacturing platform for the rapid delivery of vaccines

Online Exclusives Kristin Brooks, Contract Pharma 04.03.20

Biologics, Proteins, Vaccines

The Evolution of the ADC Manufacturer

How CMDOs can rise to the occasion

Lisa McDermott and Jyothi Swamy, MilliporeSigma 04.01.20

Ology Bio & DOD Ink COVID-19 Pact

CDMO to develop, manufacture monoconal antibody for treatment, prevention of infection with COVID-19 virus for Department of Defense

03.24.20

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development

Biogen, Vir Enter COVID-19 Antibody Alliance

Biogen will provide cell line development, process development and clinical manufacturing for Vir's monoclonal antibodies

03.13.20

Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Drug Development

COVID-19 Clinical Trials

The vaccines in development for COVID-19, who's developing them, and where they stand in the development process

Online Exclusives Kristin Brooks, Contract Pharma 03.10.20

Breaking News

Transcenta Achieves Major Milestone in Perfusion Cell Culture Platform

It will provide industry leading productivity and speed to manufacturing.

02.28.20

Bio News | Breaking News | Facilities | Industry News

Fujifilm Expands North Carolina Facility

Groundbreaking ceremony held as planned expansion work begins

02.26.20

WuXi Biologics, Vir Biotech Partner to Develop COVID-19 Antibodies

WuXi Biologics will conduct cell-line development, process and formulation development, and initial manufacturing for clinical development

02.25.20

WuXi Biologics, Vir Biotech Partner to Develop COVID-19 Antibodies

WuXi Biologics will conduct cell-line development, process and formulation development, and initial manufacturing for clinical development

02.25.20

Collaborations & Alliances | Drug Development | Drug Discovery | Information Technology

OSE Immunotherapeutics, MAbSilico Enter AI Alliance

To leverage innovative problem-solving solutions like AI for the development of new monoclonal antibodies

02.12.20

Biosimilars

The Similar Mantra

Early birds bet big on biosimilars.

S. Harachand, Contributing Editor 01.28.20

Realizing the Full Potential of Precision Medicine in Oncology

Innovation in oncology drug development is being driven by “precision medicine"

Peter Larson, Executive Medical Director, Hematology-Oncology, Premier Research 01.28.20

Breaking News

Selexis Promotes Dr. Yemi Onakunle to Chief Business Officer

Industry expert with 20+ years’ experience in biopharmaceutical drug development and manufacturing.

Selexis 01.13.20

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Avantor Boosts Biopharmaceutical Innovation in China

Opens innovation and customer support center in Shanghai.

12.11.19

Injectables

Pitfalls to Avoid When Packaging Injectable Drug Products

Addressing legacy systems, lack of innovation adoption, and special challenges of New Molecular Entities.

Fran DeGrazio, VP, Scientific Affairs and Technical Services, West Pharmaceutical Services 11.20.19

Biologics, Proteins, Vaccines | Biosimilars

Biopharma Over 20 Years

A look at the key trends that have impacted the biopharma industry over the years.

K. John Morrow, Jr. and Eric S. Langer, BioPlan Associates 11.20.19

Bio News | Breaking News | Industry News | Information Technology

Goodwin Bio Launches Digitization Initiative

Invests in a sophisticated electronic quality solution.

11.11.19

Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News

Catalent Biologics Launches GPExR Boost Cell Line Expression Technology

Designed to improve titers and cell-specific productivity.

11.05.19

Biologics, Proteins, Vaccines | Facilities

Fujifilm Eyes Being ‘Total Healthcare Company’

Invests nearly $900 million to acquire Biogen’s manufacturing hub in Denmark.

Tim Wright, Editor, Contract Pharma 10.15.19

Contract Pharma’s 20th Anniversary Retrospective

A look back a the pharma/biopharma industry and the future of outsourcing.

Kristin Brooks, Managing Editor, Contract Pharma 10.15.19

Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development

Continued and Consistent Investment in Manufacturing Facilities

As companies move their cell and gene therapies through the development process, supporting larger Phase III trials and commercial launches will be a challenge

Ryan Carpentier, Executive Director of Business Development, Cryoport 09.23.19

Cytotoxics and High Potency Manufacturing

Highly Potent Expansions

CDMOs see HPAPI demand rising

S. Harachand, Contributing Editor 09.16.19

Cytotoxics and High Potency Manufacturing

API to ADC: A Journey Through High Potency

This class of compounds represents a major advance in oncology research and treatment application.

Maurits Janssen, Head Commercial Development API, Lonza Pharma & Biotech 09.16.19

IRBM Signs Agreement with MD Anderson Cancer Center

To generate novel immune-checkpoint monoclonal antibodies

09.10.19

Fill/Finish | Injectables

Four Pitfalls to Avoid When Packaging Injectable Drug Products

Addressing legacy systems, lack of innovation adoption, and special challenges of New Molecular Entities

Fran DeGrazio, Vice President of Scientific Affairs and Technical Services, West Pharmaceutical Services, Inc. 09.04.19

Critical Factors of Fill Finish Manufacturing For Biologics

The bulk drug substance, formulation, and sterile filtering and filling of the final drug product all require special handling procedures.

Bio News | Breaking News | Collaborations & Alliances | Industry News

iBio Announces 3D Bioprinting Agreement

Focus on producing recombinant human collagen-based bioink for 3D bioprinted organ transplants

08.21.19

Biologics, Proteins, Vaccines | Drug Delivery | Injectables

Growth in Biologics and Maintaining Patient Satisfaction

Vicki A. Barbur of Battelle discusses the driving forces for biologics, the challenges, and new delivery methods

Online Exclusives Kristin Brooks, Contrct Pharma 08.09.19

Goodwin Biotechnology Bolsters Quality & Regulatory Capabilities

Names Gerald Orehostky as vice president of quality and regulatory operations

08.07.19

Pall, Servier Enter Biomanufacturing Tie-up

Pall chosen as single-source supplier for Servier’s purpose built end-to-end biomanufacturing facility in Gidy, France

07.19.19

Sanofi

...

07.15.19

Collaborations & Alliances | Industry News

Y-mAbs Secures Commercial Radiolabeling Capacity

Enters agreement with SpectronRx to produce metastatic central nervous system neuroblastoma treatment, omburtamab

07.03.19

Bio News | cGMP Manufacture | Fill/Finish

Biopharma Trends & CDMOs

Steve King of iBio discusses biopharma trends impacting CDMOs and the opportunities they present

Videos

cGMP Manufacture | Fill/Finish | Industry News

iBio Inks First Fill-Finish Services Agreement

To provide cGMP sterile fill-finish for the customer’s investigational therapy for late-stage clinical trial

06.19.19

Biologics, Proteins, Vaccines

The ADC Market is Fast Evolving

Applications of ADCs are widening and improvements in the manufacturing process meet industry requirements.

Charlie Johnson, CEO, ADC Bio 06.13.19

Bio News | cGMP Manufacture | Fill/Finish | Industry News

iBio Launches Sterile Fill-Finish Services

Initial capacity supports 100 – 2,500 vials runs, with plans to expand to 15,000

06.03.19

Bio News | Biologics, Proteins, Vaccines | Drug Development

Catalent Launches OneBio Suite

Aims to address the challenges facing biologic development companies that are looking to accelerate programs to clinic or market

05.24.19

Bio News | Breaking News | Facilities | Industry News

SGS Opens Biologics Testing Facility in UK

Receives Scottish Enterprise grant of £1.7 million, as a contribution towards the company’s £7.6 million investment

05.22.19

Biologics, Proteins, Vaccines

The Biopharma Future

A look at current trends driving volume reductions in biopharmaceutical manufacturing and keys for successful outsourcing partnerships.

Karl Pinto and Dave Cunningham, Goodwin Biotechnology 05.07.19

Bio News | Breaking News | cGMP Manufacture | Facilities | Industry News

Goodwin Biotechnology Readies for Expansion

Secures significant investment in new round of growth capital financing

04.25.19

Collaborations & Alliances

Lilly, Avidity Biosciences Enter Global R&D Alliance

Will leverage Avidity's technology platform for the discovery, development and commercialization of potential new medicines in immunology and other indications

04.22.19

Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

Ology Wins Two DoD Awards

Together totals more than $135 million

04.17.19

Bio News | Industry News

CEVEC Expands AAV Production Platform

Secures funding to expand commercialization of CAP GT-based stable adeno-associated viral (AAV) vector production platform

04.16.19

Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

Fujifilm Accelerates Cell Line Devt. Timelines

Introduces a 10-week timeline with its Apollo X Advanced Mammalian Expression System

04.11.19

Bio News | cGMP Manufacture | Collaborations & Alliances | Industry News | R&D

Alvotech, Fuji Pharma Sign Commercialization Agreement

For the exclusive partnership and supply to commercialize Alvotech’s ustekinumab biosimilar (Stelara) in Japan

04.09.19

3P Enters Mfg. Tie-up With Dutch Biotech Xenikos

3P responsible for process transfer and scale-up, cGMP production for clinical trials and process validation

03.12.19

Bio News | Breaking News | cGMP Manufacture | Facilities

Goodwin Biotechnology Expands Capacity

Invests in doubling space available for cGMP capacity as it readies for further expansion of its biopharma manufacturing business

03.08.19

Biologics, Proteins, Vaccines

Immuno-oncology Safety Assessment

Taking the brakes off the immune system with checkpoint inhibitor antibodies.

Dr. Kirsty Harper, Head of Biologics, Envigo 03.06.19

Imbrium, TetraGenetics Enter Biologics Discovery Collaboration

Partnership will focus on development of novel biologic therapeutics for pain using TetraExpress

02.26.19

FOLLOW:

Search Results for 'monoclonal antibodies'

Contract Service Directory Companies

Microsite Companies

Featured Companies

September 2021

follow us